Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-2-28
pubmed:abstractText
Bulky mediastinal involvement is a challenging presentation of Hodgkin's disease (HD). Radiotherapy alone has provided a good response rate but also a high percentage of recurrences, and therefore many studies have been initiated to evaluate combined modality treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0390-6078
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-5
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:7507457-Actuarial Analysis, pubmed-meshheading:7507457-Adolescent, pubmed-meshheading:7507457-Adult, pubmed-meshheading:7507457-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7507457-Bleomycin, pubmed-meshheading:7507457-Combined Modality Therapy, pubmed-meshheading:7507457-Dacarbazine, pubmed-meshheading:7507457-Doxorubicin, pubmed-meshheading:7507457-Etoposide, pubmed-meshheading:7507457-Female, pubmed-meshheading:7507457-Hodgkin Disease, pubmed-meshheading:7507457-Humans, pubmed-meshheading:7507457-Infertility, pubmed-meshheading:7507457-Lomustine, pubmed-meshheading:7507457-Male, pubmed-meshheading:7507457-Mechlorethamine, pubmed-meshheading:7507457-Mediastinal Neoplasms, pubmed-meshheading:7507457-Middle Aged, pubmed-meshheading:7507457-Prednimustine, pubmed-meshheading:7507457-Prednisone, pubmed-meshheading:7507457-Procarbazine, pubmed-meshheading:7507457-Prospective Studies, pubmed-meshheading:7507457-Radiotherapy, High-Energy, pubmed-meshheading:7507457-Remission Induction, pubmed-meshheading:7507457-Salvage Therapy, pubmed-meshheading:7507457-Survival Analysis, pubmed-meshheading:7507457-Treatment Outcome, pubmed-meshheading:7507457-Vinblastine, pubmed-meshheading:7507457-Vincristine
pubmed:articleTitle
Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
pubmed:affiliation
Division of Medical Oncology, Oncology Institute, Bari, Italy.
pubmed:publicationType
Journal Article, Clinical Trial